Lorenz Plot Analysis for Ventricular Cycle Length Discrimination
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current medical devices struggle to accurately detect and discriminate between atrial fibrillation (AF) and organized atrial tachycardia (OAT) in single chamber implantable devices and external monitors, as they lack an atrial signal source, which is essential for distinguishing these arrhythmias.
Innovation Solution
The method employs a Lorenz plot analysis of ventricular cycle lengths to generate cluster signature metrics, using a two-dimensional or one-dimensional histogram representation, allowing for the detection and discrimination of AF and OAT without requiring an atrial signal, by analyzing beat-to-beat differences in ventricular cycle lengths and their patterns.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If dual chamber implantable devices with both atrial and ventricular EGM signals are used, then arrhythmia discrimination reliability is improved, but device complexity and cost increase
Solution Approach 1:
The patent extracts and utilizes only the ventricular EGM signal and RR interval data, eliminating the need for atrial EGM signals while maintaining arrhythmia discrimination capability. This extraction approach allows single-chamber devices to achieve dual-chamber level diagnostic accuracy without requiring complex multi-sensor hardware.
Solution Approach 2:
The patent introduces Lorenz plot analysis as an intermediary computational method that transforms ventricular cycle length sequences into diagnostic patterns. This intermediary analysis layer enables the system to infer atrial arrhythmia characteristics from ventricular responses, bridging the gap between limited sensor data and comprehensive diagnostic needs.
2Device complexity
If single chamber implantable devices without atrial signal are used, then device complexity is reduced, but arrhythmia detection accuracy deteriorates
Solution Approach 1:
Instead of directly measuring atrial signals to detect arrhythmias, the patent inverts the approach by analyzing ventricular cycle length patterns that are secondarily affected by atrial arrhythmias. The Lorenz plot of RR intervals reveals characteristic patterns that indirectly indicate atrial fibrillation or organized atrial tachycardia, achieving accurate detection through inverted measurement logic.
Solution Approach 2:
The patent replaces direct electrical signal measurement from the atrium with computational analysis of ventricular rhythm patterns. By substituting the mechanical/electrical measurement approach with information processing and pattern recognition algorithms, the system achieves arrhythmia detection without requiring physical access to atrial tissue or atrial lead placement.
3Ease of operation
If external monitors without atrial lead are used, then ease of operation is improved, but discrimination capability between AF and OAT deteriorates
Solution Approach 1:
The patent makes the ventricular EGM signal serve multiple diagnostic functions: it simultaneously detects arrhythmia presence, characterizes arrhythmia type (AF vs OAT), and provides rhythm classification. This multi-functional utilization of a single signal type compensates for the absence of atrial leads, restoring discrimination capability that would otherwise be lost in external monitoring scenarios.
Data Source
AI summary
A method and apparatus for detecting atrial arrhythmias and discriminating atrial fibrillation (AF) and organized atrial tachycardia (OAT) that includes defining a threshold detection criteria for a cluster signature evidence metric corresponding to a Lorenz distribution of ventricular cycle lengths representative of AF or OAT. Using a signal containing VCL information, a number of consecutive ventricular cycle lengths are determined during a selected time interval for generating a one-dimensional or a two-dimensional histogram as a numerical representation of a Lorenz plot of VCLs. A number of cluster signature metrics are computed using the stored ventricular cycle length information, and a cluster signature evidence metric is computed from the cluster signature metrics. AF or OAT is detected if a comparative analysis of a corresponding cluster signature evidence metric meets a respective threshold detection criteria.